TRERF1

Across TCGA pan-cancer cohorts, TRERF1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TRERF1 data layer compared with 26 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher TRERF1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated TRERF1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

PDAC, LUAD, and HNSC are the cancer types where TRERF1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	II,III,IV	0.252	0.651	.001	10	view →
LUAD	DFS	Median	III,IV	0.993	0.483	.022	1	view →
HNSC	OS	Quartile	IV	0.925	0.613	.023	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TRERF1–PDAC (OS)

Open the PDAC breakdown →